José Luiz Martins Do Nascimento has degrees in Biological
Sciences from the Federal University of Para (1977) and Medicine from the
Federal University of Para (1979), a Master’s degree in Biological Sciences
(Biophysics) from the Federal University of Rio de Janeiro (1984), a Doctorate
degree in Biological Sciences (Biophysics) from the Federal University of Rio
de Janeiro (1995) and a Post-Doctorate at the Vollum Institute—OHSU, USA (1998–1999).
He was a director of the Institute of Biological Sciences at UFPA during 2006–2010.
He is a former full professor at CEUMA University and a retired senior
researcher at the Federal University of Para. He has experience in biochemistry
and pharmacology, with an emphasis on neurochemistry, neuropharmacology, and neuroinflammation,
working mainly on the following subjects: differentiation of retinal tissue,
neurotoxic action of methylmercury in the CNS, release and uptake of
neurotransmitters, measurement of enzyme activity and development of experimental
models of pharmacological interest.
José Luiz Martins Do Nascimento has degrees in Biological
Sciences from the Federal University of Para (1977) and Medicine from the
Federal University of Para (1979), a Master’s degree in Biological Sciences
(Biophysics) from the Federal University of Rio de Janeiro (1984), a Doctorate
degree in Biological Sciences (Biophysics) from the Federal University of Rio
de Janeiro (1995) and a Post-Doctorate at the Vollum Institute—OHSU, USA (1998–1999).
He was a director of the Institute of Biological Sciences at UFPA during 2006–2010.
He is a former full professor at CEUMA University and a retired senior
researcher at the Federal University of Para. He has experience in biochemistry
and pharmacology, with an emphasis on neurochemistry, neuropharmacology, and neuroinflammation,
working mainly on the following subjects: differentiation of retinal tissue,
neurotoxic action of methylmercury in the CNS, release and uptake of
neurotransmitters, measurement of enzyme activity and development of experimental
models of pharmacological interest.